journal
https://read.qxmd.com/read/38383040/experts-by-lived-experience-enhancing-the-patient-provider-relationship-through-patient-stories
#1
JOURNAL ARTICLE
Tammy Hua, Gregg Martin, Alex Leow
No abstract text is available yet for this article.
February 21, 2024: Bipolar Disorders
https://read.qxmd.com/read/38326104/metabolomic-biomarkers-for-r-s-ketamine-and-s-ketamine-in-treatment-resistant-depression-and-healthy-controls-a-systematic-review
#2
REVIEW
Rakesh Kumar, Nicolas A Nuñez, Neha Joshi, Boney Joseph, Alessandra Verde, Ashok Seshadri, Alfredo B Cuellar Barboza, Larry J Prokop, Gustavo C Medeiros, Balwinder Singh
BACKGROUND: Ketamine is increasingly used for treatment-resistant depression (TRD) while its mechanism of action is still being investigated. In this systematic review, we appraise the current evidence of metabolomic biomarkers for racemic ketamine and esketamine in patients with TRD and healthy controls (HCs). METHODS: A comprehensive search of several databases (Ovid MEDLINE®, Embase, and Epub Ahead of Print) was performed from each database's inception to June 29, 2022, in any language, was conducted...
February 7, 2024: Bipolar Disorders
https://read.qxmd.com/read/38320751/late-onset-delirious-mania-does-it-ring-a-bell
#3
REVIEW
Maria Aa Hansen, Robert Bering, Anders Spanggård, Pedro Barata
BACKGROUND: Bell's mania was first described in 1849, and other terms have been used to describe this condition, including delirious mania, mania with delirium, and excited delirium. However, no international diagnostic manual has included mania as an independent diagnostic tool. The criteria for delirious mania were proposed by Bond et al. METHODS: We present a case of a man without a personal or family psychiatric history who experienced his first manic episode of delirium and psychosis at 76 years old...
February 6, 2024: Bipolar Disorders
https://read.qxmd.com/read/38311367/anhedonia-in-bipolar-depression-treated-with-ketamine
#4
JOURNAL ARTICLE
Alina Wilkowska, Mariusz S Wiglusz, Aleksandra Arciszewska-Leszczuk, Maria Gałuszko-Węgielnik, Wiesław J Cubała
BACKGROUND: Bipolar depression is the major cause of morbidity in patients with bipolar disorder. It affects psychosocial functioning and markedly impairs occupational productivity. Anhedonia is one of the most debilitating symptoms of depression contributing to treatment resistance. It correlates with suicidality, low quality of life, social withdrawal, and poor treatment response. Currently, there is no approved treatment specifically targeting anhedonia. Emerging evidence suggests that ketamine possesses anti-anhedonic properties in individuals with depression...
February 4, 2024: Bipolar Disorders
https://read.qxmd.com/read/38302845/is-peripartum-anhedonia-a-missing-target
#5
LETTER
Marianna Mazza, Giuseppe Marano
The perinatal period is an extremely delicate phase that can involve a high risk for onset of depressive disorders. The Edinburgh Postnatal Depression Scale (EPDS) is a widely validated instrument for assessing perinatal depressive symptoms, including the dimension of anhedonia. There are studies suggesting that the neural mechanism underlying the occurrence of anhedonia in patients with major depressive disorder (MDD) and bipolar depression (BD) might be distinct. Anhedonia seems to represent a more stable and frequent symptom in women with postpartum bipolar relative to unipolar depressive disorder and is associated with significantly higher depressive symptom severity...
February 1, 2024: Bipolar Disorders
https://read.qxmd.com/read/38302731/fostering-networking-opportunities-and-creating-a-community-of-early-and-mid-career-clinicians-and-researchers-within-the-international-society-for-bipolar-disorders
#6
JOURNAL ARTICLE
Fabiano A Gomes, Rebekah S Huber, Sarah H Sperry, Tamsyn E Van Rheenen
No abstract text is available yet for this article.
February 1, 2024: Bipolar Disorders
https://read.qxmd.com/read/38286441/correction-to-supercharging-collaboration-for-bipolar-research-breakthrough-discoveries-for-thriving-with-bipolar-disorder-bd-2
#7
(no author information available yet)
No abstract text is available yet for this article.
January 29, 2024: Bipolar Disorders
https://read.qxmd.com/read/38279682/a-comment-and-correction
#8
LETTER
Rasmus W Licht, René E Nielsen
No abstract text is available yet for this article.
January 27, 2024: Bipolar Disorders
https://read.qxmd.com/read/38263712/a-needless-contest
#9
JOURNAL ARTICLE
Michael J Gitlin
No abstract text is available yet for this article.
January 23, 2024: Bipolar Disorders
https://read.qxmd.com/read/38258551/occurrence-of-postpartum-manic-or-mixed-episodes-in-women-with-bipolar-i-disorder-a-systematic-review-and-meta-analysis
#10
REVIEW
Verinder Sharma, Katelyn N Wood, Bruce Weaver, Dwight Mazmanian, Michael Thomson
OBJECTIVE: Accurate information on the frequency and prevalence of manic or mixed episodes is important for therapeutic, prognostic, and safety concerns. We aimed to estimate the risk of relapse of manic and mixed episodes after delivery in women with bipolar I disorder or schizoaffective disorder-bipolar type. METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a comprehensive literature search in PubMed, PsycINFO, Embase, and Cochrane databases was carried out on November 17, 2022, using the terms ((bipolar disorder) OR (manic depressive illness)) AND (mania)) AND (postpartum)) AND (recurrence)) AND (relapse)...
January 23, 2024: Bipolar Disorders
https://read.qxmd.com/read/38253983/valproate-induced-hyperammonemia-neuroleptic-sensitivity-and-cerebellar-atrophy-a-clinical-conundrum-in-the-management-of-bipolar-disorder
#11
JOURNAL ARTICLE
Samarth S Shetty, Harshitha H AnnajiGowda, Ajit Bhalchandra Dahale
OBJECTIVE: Treatment of bipolar disorder (BD) involves complexities especially when patients come with significant sensitivity to various psychotropic medications and comorbidities. The following cases aim to recapitulate and discuss some of such situations. CASES: Case 1: A 36-year-old man with intellectual development disorder and BD experienced catatonia, seizures, and hyperammonemia following valproate administration. Treatment involved electroconvulsive therapy (ECT) and a tailored medication regimen, ultimately leading to stability...
January 22, 2024: Bipolar Disorders
https://read.qxmd.com/read/38238101/comment-on-published-article-a-chat-about-bipolar-disorder
#12
LETTER
Hinpetch Daungsupawong, Viroj Wiwanitkit
To the Editor, we follow the topic "A chat about bipolar disorder1 ". According to the study's findings, ChatGPT proved its ability to deliver basic and informative information on bipolar disorders.
January 18, 2024: Bipolar Disorders
https://read.qxmd.com/read/38238083/myelinolysis-cases-presenting-with-manic-attack-after-rapid-correction-of-hyponatremia-two-cases
#13
JOURNAL ARTICLE
Muhammed Emin Boylu, İsmet Kırpınar
OBJECTIVE: Myelinolysis is a neurological condition that can display diverse psychiatric symptoms, with electrolyte imbalance, alcoholism and malnutrition being the frequent causes. Rapid correction of hyponatremia may trigger pontine and extra-pontine myelinolysis. CASES: This paper examines two cases: one of hyponatremia after antihypertensive use and the other of myelinolysis due to rapid correction of hyponatremia. Since myelinolysis appeared as a manic episode, the patients sought treatment at the psychiatry outpatient clinic...
January 18, 2024: Bipolar Disorders
https://read.qxmd.com/read/38151476/invited-commentary-to-professor-belmaker-s-letter-on-lithium-treatment-for-bipolar-disorder
#14
JOURNAL ARTICLE
Rasmus W Licht, René E Nielsen
No abstract text is available yet for this article.
December 27, 2023: Bipolar Disorders
https://read.qxmd.com/read/38097824/utilizing-plasma-drug-levels-and-genetic-testing-to-achieve-optimal-treatment-response-in-a-patient-with-treatment-resistant-schizoaffective-disorder
#15
JOURNAL ARTICLE
Jin-Jie Xu, Chunfeng Xiao, Yanli Pan, Yi-Lang Tang, Mingwan Wang, Sheng Li, Gaoming Xie, Jing Du, Yanping Ren, Wei Wang
We report the case of a Chinese male with schizoaffective disorder, an active smoker and a nonresponder to clozapine (600 mg daily). Therapeutic clozapine monitoring was analyzed, revealing a low concentration-dose ratio. A pharmacogenetic test showed that the patient had the CYP1A2*1F/*1F genotype, indicating an ultra-rapid clozapine metabolizer. In combination with fluvoxamine, a CYP1A2 enzyme inhibitor, clozapine plasma concentrations approached the reference range and achieved clinical improvement...
December 14, 2023: Bipolar Disorders
https://read.qxmd.com/read/38054521/breaking-tradition-a-case-report-on-successfully-treating-psoriasis-in-a-patient-with-bipolar-disorders-using-biologics-without-discontinuing-lithium
#16
JOURNAL ARTICLE
Cuniberti Francesco, Ribero Simone, Ortoncelli Michela, Avetta Cecilia, Leombruni Paolo, Oliva Francesco
No abstract text is available yet for this article.
December 6, 2023: Bipolar Disorders
https://read.qxmd.com/read/38127002/supercharging-collaboration-for-bipolar-research-breakthrough-discoveries-for-thriving-with-bipolar-disorder-bd-2
#17
EDITORIAL
C M Altimus, E G Baxi, M A Frye, E J Nestler, D L Pham, K E Burdick
No abstract text is available yet for this article.
December 2023: Bipolar Disorders
https://read.qxmd.com/read/37984974/shifting-from-prevention-of-the-next-episode-to-optimizing-inter-episodic-functioning-commentary-on-the-neuroprogression-hypothesis-in-bipolar-disorders-time-for-apologies
#18
JOURNAL ARTICLE
Annemiek Dols, Sigfried Schouws, Melis Orhan, Alexandra Beunders
No abstract text is available yet for this article.
December 2023: Bipolar Disorders
https://read.qxmd.com/read/37926524/use-of-botulinum-toxin-a-for-depression-symptoms-in-patients-with-treatment-resistant-bipolar-illness-a-case-series
#19
JOURNAL ARTICLE
Ali A Farooqui, Jessica M Fulkerson, Rif S El-Mallakh
No abstract text is available yet for this article.
December 2023: Bipolar Disorders
https://read.qxmd.com/read/38015080/aversive-agents-think-twice-a-case-report-on-disulfiram-induced-mania
#20
JOURNAL ARTICLE
María Fernanda González-Romero, José María Martínez-Ávila, Elizabeth Moloney, Ignacio García-Cabeza
We present a case of disulfiram-induced mania in a patient with both alcohol use disorder (AUD) and psychostimulant use disorder (PUD), without a history of psychosis or mania. This acute presentation may be linked to the increased dopamine levels caused by disulfiram metabolism. Our patient developed manic symptoms 10 days after starting disulfiram, prescribed to treat the AUD. It should be noted that the symptoms resolved rapidly after disulfiram cessation during hospitalization. Disulfiram use is an effective treatment for alcohol dependence...
November 27, 2023: Bipolar Disorders
journal
journal
34596
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.